Volume 20, Number 7—July 2014
Dispatch
Neisseria gonorrhoeae Strain with Reduced Susceptibilities to Extended-Spectrum Cephalosporins
Table 2
Table 2. MICs required for Neisseria gonorrhoeae isolates of the 5 most common genogroups in 4 counties in California, USA, 2012* |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Genogroup | Cefixime, no. (%) |
Ceftriaxone, no. (%) |
Azithromycin, no. (%) |
||||||||
Low | Intermediate | High | Low | Intermediate | High | Low | Intermediate | High | |||
2992 | 69 (98.5) | 1 (0.015) | 0 | 70 (100) | 0 | 0 | 52 (74.3) | 18 (25.7) | 0 | ||
2400 | 19 (32) | 40 (68) | 0 | 8 (13.6) | 51 (86.4) | 0 | 55 (93) | 4 (7) | 0 | ||
3307 | 51 (98) | 1 (2) | 0 | 51 (98) | 1 (2) | 0 | 50 (96) | 2 (4) | 0 | ||
1407 | 4 (9) | 27 (60) | 14 (31) | 7 (15.5) | 28 (62.2) | 10 (22.3) | 26 (58) | 19 (42) | 0 | ||
3935 | 30 (97) | 1 (3) | 0 | 30 (97) | 1 (3) | 0 | 14 (45) | 17 (55) | 0 | ||
Other | 436 (94.5) | 24 (5) | 1 (0.5) | 384 (83.3) | 76 (16.5) | 1 (0.02) | 432 (94) | 27 (5.8) | 2 (0.2) |
*Cefixime: low ≤0.023 μg/mL, intermediate 0.032–0.094 μg/mL, high ≥0.125 μg/mL; ceftriaxone: low ≤0.023 μg/mL, intermediate 0.032–0.094 μg/mL, high ≥0.125 μg/mL; azithromycin: low ≤0.380 μg/mL, intermediate 0.5–1.5 μg/mL, high ≥2.0 μg/mL.
Page created: June 17, 2014
Page updated: June 17, 2014
Page reviewed: June 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.